BR0205509A - Composição compreendendo partìculas finas de liberação prolongada para comprimidos de rápida desintegração na cavidade bucal e método de fabricação da mesma - Google Patents
Composição compreendendo partìculas finas de liberação prolongada para comprimidos de rápida desintegração na cavidade bucal e método de fabricação da mesmaInfo
- Publication number
- BR0205509A BR0205509A BR0205509-0A BR0205509A BR0205509A BR 0205509 A BR0205509 A BR 0205509A BR 0205509 A BR0205509 A BR 0205509A BR 0205509 A BR0205509 A BR 0205509A
- Authority
- BR
- Brazil
- Prior art keywords
- fine particles
- composition
- rapidly disintegrating
- oral cavity
- release fine
- Prior art date
Links
- 239000010419 fine particle Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 210000000214 mouth Anatomy 0.000 title abstract 3
- 238000000034 method Methods 0.000 title 1
- 235000000346 sugar Nutrition 0.000 abstract 3
- 239000011230 binding agent Substances 0.000 abstract 2
- 238000013265 extended release Methods 0.000 abstract 2
- 150000008163 sugars Chemical class 0.000 abstract 2
- 150000001298 alcohols Chemical class 0.000 abstract 1
- 239000000945 filler Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000006187 pill Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
Abstract
"COMPOSIçãO COMPREENDENDO PARTìCULAS FINAS DE LIBERAçãO PROLONGADA PARA COMPRIMIDOS DE RáPIDA DESINTEGRAçãO NA CAVIDADE BUCAL E MéTODO DE FABRICAçãO DA MESMA". A presente invenção refere-se a uma composição compreendendo partículas finas de liberação prolongada, caracterizada por conter partículas finas de liberação prolongada podendo ser usadas nos comprimidos de rápida desintegração na cavidade bucal, uma ou mais cargas selecionadas do grupo que consiste de açúcares ou álcoois de açúcar e um ou mais aglutinantes para comprimidos de rápida desintegração na cavidade bucal selecionados do grupo que consiste de açúcares de alta moldabilidade e substâncias poliméricas hidrossolúveis, e em que as partículas finas de liberação prolongada são granuladas com carga e aglutinante para comprimidos de rápida desintegração na cavidade bucal, e um método de fabricação da composição.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30830301P | 2001-07-27 | 2001-07-27 | |
PCT/JP2002/007550 WO2003009831A1 (en) | 2001-07-27 | 2002-07-25 | Compositions containing sustained-release fine grains for tablets quickly disintegrable in the oral cavity and process for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0205509A true BR0205509A (pt) | 2003-06-24 |
Family
ID=23193419
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0205509-0A BR0205509A (pt) | 2001-07-27 | 2002-07-25 | Composição compreendendo partìculas finas de liberação prolongada para comprimidos de rápida desintegração na cavidade bucal e método de fabricação da mesma |
Country Status (18)
Country | Link |
---|---|
US (2) | US7255876B2 (pt) |
EP (1) | EP1413294B1 (pt) |
JP (3) | JP4019374B2 (pt) |
KR (1) | KR100530546B1 (pt) |
CN (1) | CN1473035B (pt) |
AT (1) | ATE482692T1 (pt) |
AU (1) | AU2002355222B2 (pt) |
BR (1) | BR0205509A (pt) |
CA (1) | CA2419089A1 (pt) |
CZ (1) | CZ14921U1 (pt) |
DE (2) | DE60237826D1 (pt) |
ES (1) | ES2351249T3 (pt) |
HU (1) | HUP0302351A3 (pt) |
MX (1) | MXPA03000985A (pt) |
PL (1) | PL361452A1 (pt) |
RU (1) | RU2245136C2 (pt) |
WO (1) | WO2003009831A1 (pt) |
ZA (1) | ZA200300647B (pt) |
Families Citing this family (91)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7815937B2 (en) * | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
AU1323400A (en) * | 1998-10-27 | 2000-05-15 | Fuisz Technologies Ltd. | Microparticles containing peg and/or peg glyceryl esters |
JP4019374B2 (ja) * | 2001-07-27 | 2007-12-12 | アステラス製薬株式会社 | 口腔内速崩壊錠用徐放性微粒子含有組成物およびその製造法 |
NZ532589A (en) * | 2001-11-07 | 2005-02-25 | Synthon Bv | Tamsulosin tablets |
JP4173670B2 (ja) * | 2002-03-08 | 2008-10-29 | 旭化成ファーマ株式会社 | 口腔内崩壊製剤 |
DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
DE10244504A1 (de) * | 2002-09-25 | 2004-04-08 | Capsulution Nanoscience Ag | Schnellfreisetzende Darreichungsform mit schwerlöslichem Wirkstoff |
JP4523265B2 (ja) * | 2002-11-13 | 2010-08-11 | 旭化成ファーマ株式会社 | 排尿障害治療用口腔内崩壊製剤 |
CA2515585A1 (en) * | 2003-01-27 | 2004-08-12 | Yoji Tanijiri | Enteric sustained-release fine particles for tamsulosin or its salt and manufacturing method thereof |
ZA200409537B (en) | 2003-01-31 | 2006-10-25 | Yamanouchi Pharma Co Ltd | Stable solid medicinal composition for oral administration |
DE60300414T2 (de) * | 2003-04-30 | 2006-05-11 | Ferring B.V. | Feste Dosierungsform mit Desmopressin |
DE60308828T2 (de) * | 2003-05-20 | 2007-05-24 | Ethypharm | Orale pharmazeutische Zusammensetzung mit verzögerter Freisetzung |
US7314638B2 (en) * | 2003-08-12 | 2008-01-01 | Kyungdong Pharm. Co., Ltd. | Preparing method for controlled released type tablet tamsulosin HCL and the tablet thereof |
US20070122480A1 (en) * | 2003-09-29 | 2007-05-31 | Cj Corporation | Sustained release formulations |
CN100438914C (zh) * | 2003-10-15 | 2008-12-03 | 富士化学工业株式会社 | 用于口腔内快速崩解的片剂的组合物 |
KR101159617B1 (ko) | 2003-10-15 | 2012-06-27 | 후지카가쿠고교가부시키가이샤 | 구강내 속붕해성 정제 |
DE10350322A1 (de) * | 2003-10-23 | 2005-06-09 | Coty B.V. | Klimabeständiger kosmetischer Komplex |
JPWO2005039542A1 (ja) * | 2003-10-27 | 2007-02-15 | アステラス製薬株式会社 | 口腔内崩壊錠用の薬物含有被覆微粒子 |
US8197846B2 (en) | 2003-11-10 | 2012-06-12 | Astellas Pharma Inc. | Sustained release pharmaceutical composition |
US8128958B2 (en) | 2003-11-10 | 2012-03-06 | Astellas Pharma Inc. | Sustained release pharmaceutical composition |
WO2005053659A1 (en) * | 2003-12-03 | 2005-06-16 | Natco Pharma Limited | An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation |
SI21637A (sl) * | 2003-12-23 | 2005-06-30 | LEK farmacevtska dru�ba d.d. | Farmacevtska oblika z nadzorovanim sproščanjem |
KR100582350B1 (ko) * | 2004-02-17 | 2006-05-22 | 한미약품 주식회사 | 탐수로신 염산염의 경구투여용 조성물 및 이의 서방성과립 제제 |
CN1988884B (zh) * | 2004-06-10 | 2013-01-02 | 格拉特气体技术公司 | 控制释放基质的药物剂型组成 |
DE102004028940A1 (de) * | 2004-06-15 | 2006-01-12 | Krka Tovarna Zdravil, D.D. | Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält |
ES2287613T3 (es) * | 2004-07-14 | 2007-12-16 | Siegfried Generics International Ag | Granulado para la liberacion controlada de tamsulosina, que contiene alginato. |
PL204079B1 (pl) * | 2004-08-12 | 2009-12-31 | Inst Farmaceutyczny | Stały doustny preparat chlorowodorku tamsulozyny o przedłużonym uwalnianiu i sposób jego wytwarzania |
US8871273B2 (en) | 2005-02-25 | 2014-10-28 | Takeda Pharmaceutical Company Limited | Method for producing granules |
DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
DE102005009240A1 (de) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
ITBO20050123A1 (it) * | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
WO2006115285A1 (ja) * | 2005-04-21 | 2006-11-02 | Takeda Pharmaceutical Company Limited | 医薬組成物 |
CA2604617C (en) * | 2005-04-28 | 2014-06-17 | Eisai R&D Management Co., Ltd. | Composition containing anti-dementia drug |
US20070048369A1 (en) * | 2005-08-26 | 2007-03-01 | National Starch And Chemical Investment Holding Corporation | Mucosal delivery tablet |
CA2620738C (en) * | 2005-08-31 | 2010-10-12 | Ezaki Glico Co., Ltd. | Tablet for removing tongue coating |
US7811604B1 (en) | 2005-11-14 | 2010-10-12 | Barr Laboratories, Inc. | Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same |
JP5365777B2 (ja) | 2006-09-15 | 2013-12-11 | アステラス製薬株式会社 | 光に対して安定なラモセトロンの固形医薬組成物 |
CN101854920B (zh) | 2007-10-19 | 2013-05-01 | 大塚制药株式会社 | 基质型药物固体制剂 |
AU2009214307A1 (en) * | 2008-02-13 | 2009-08-20 | Bayer Intellectual Property Gmbh | Drug delivery system with stabilising effect |
BRPI0908477A2 (pt) * | 2008-02-13 | 2018-03-27 | Bayer Schering Pharma Ag | sistema de distribuição de medicamento contendo estradiol |
JP5572321B2 (ja) * | 2008-03-07 | 2014-08-13 | 沢井製薬株式会社 | 被覆微粒子含有口腔内崩壊錠 |
ES2332168B1 (es) * | 2008-04-30 | 2010-10-27 | Consejo Superior De Investigaciones Cientificas (Csic) (75%) | Forma pseudopolimorfica de hidrocloruro de nicardipina, procedimiento para su preparacion y formulacion que la contiene. |
EP2308483A4 (en) * | 2008-07-01 | 2014-09-10 | Sawai Seiyaku Kk | PROCESS FOR PRODUCING SPHERICAL MICROPARTICLES COMPRISING TAMSULOSINE CHLORHYDRATE |
CN101639340B (zh) * | 2008-08-01 | 2011-01-12 | 广东省计量科学研究院 | 读数显微镜检定装置 |
MX2011003047A (es) | 2008-09-24 | 2011-04-14 | Evonik Roehm Gmbh | Composicion farmaceutica de opioide de liberacion controlada ph dependiente con resistencia contra la influencia de etanol. |
EP2177215A1 (en) | 2008-10-17 | 2010-04-21 | Laboratorios Del. Dr. Esteve, S.A. | Co-crystals of tramadol and NSAIDs |
US9284307B2 (en) | 2009-08-05 | 2016-03-15 | Idenix Pharmaceuticals Llc | Macrocyclic serine protease inhibitors |
UY32836A (es) | 2009-08-12 | 2011-03-31 | Bayer Schering Pharma Ag | Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato |
CA2771358A1 (en) | 2009-08-19 | 2011-02-24 | Sascha General | Drug delivery systems (wafer) for pediatric use |
TWI491395B (zh) | 2009-09-30 | 2015-07-11 | Ct Lab Inc | 一種內含用以治療神經退化性疾病之立即釋出與長效釋出藥物的口服劑量配方 |
WO2011056764A1 (en) | 2009-11-05 | 2011-05-12 | Ambit Biosciences Corp. | Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles |
MY159958A (en) | 2009-12-18 | 2017-02-15 | Idenix Pharmaceuticals Inc | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
SG10201504529WA (en) * | 2010-03-09 | 2015-07-30 | Alkermes Pharma Ireland Ltd | Alcohol Resistant Enteric Pharmaceutical Compositions |
WO2011112689A2 (en) | 2010-03-11 | 2011-09-15 | Ambit Biosciences Corp. | Saltz of an indazolylpyrrolotriazine |
JP5648303B2 (ja) * | 2010-03-19 | 2015-01-07 | 味の素株式会社 | 耐吸湿固結性を有する粉体造粒物の製造方法および粉体造粒物 |
KR101423237B1 (ko) * | 2010-05-04 | 2014-07-30 | 주식회사 삼양바이오팜 | 탐스로신 또는 이의 약학적으로 허용 가능한 염을 포함하는 방출 제어용 약학 조성물, 및 이를 포함하는 경구용 제제 |
MX2013002383A (es) | 2010-09-01 | 2013-07-05 | Ambit Biosciences Corp | Sales bromhidrato de una pirazolilaminoquinazolina. |
ES2581840T3 (es) | 2010-09-01 | 2016-09-07 | Ambit Biosciences Corporation | Pirazolilaminoquinazolina ópticamente activa y composiciones farmacéuticas y métodos de uso de la misma |
BR112013014021A8 (pt) | 2010-12-06 | 2017-10-03 | Follica Inc | Métodos para tratamento de calvície e promoção de crescimento de cabelos |
WO2012080050A1 (en) | 2010-12-14 | 2012-06-21 | F. Hoffmann-La Roche Ag | Solid forms of a phenoxybenzenesulfonyl compound |
KR101111534B1 (ko) * | 2010-12-24 | 2012-02-15 | (주)비씨월드제약 | 구강 속붕해성 조성물 및 이의 제조방법 |
CA2825152A1 (en) | 2011-01-31 | 2012-08-09 | Celgene Corporation | Pharmaceutical compositions of cytidine analogs and methods of use thereof |
US9353100B2 (en) | 2011-02-10 | 2016-05-31 | Idenix Pharmaceuticals Llc | Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections |
US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
WO2013019056A1 (en) * | 2011-08-01 | 2013-02-07 | Sam-A Pharm. Co., Ltd. | Novel granule formulation containing sildenafil or pharmaceutically acceptable salts thereof as an active ingredient |
ES2763579T3 (es) | 2012-01-27 | 2020-05-29 | Univ California | Estabilización de biomoléculas con polímeros de azúcar |
WO2013138613A1 (en) | 2012-03-16 | 2013-09-19 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
KR101778050B1 (ko) * | 2012-10-12 | 2017-09-13 | 이에이 파마 가부시키가이샤 | 칼슘 길항약/안지오텐신 ii 수용체 길항약 함유 의약 제제의 제조 방법 |
KR102237799B1 (ko) | 2012-11-14 | 2021-04-08 | 더블유.알. 그레이스 앤드 캄파니-콘. | 생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물 |
CN103230379A (zh) * | 2013-04-02 | 2013-08-07 | 万特制药(海南)有限公司 | 一种含有盐酸坦索罗辛的口崩缓释制剂及其制备方法 |
NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
EP3046924A1 (en) | 2013-09-20 | 2016-07-27 | IDENIX Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
WO2015134560A1 (en) | 2014-03-05 | 2015-09-11 | Idenix Pharmaceuticals, Inc. | Solid forms of a flaviviridae virus inhibitor compound and salts thereof |
KR20240064750A (ko) | 2014-03-20 | 2024-05-13 | 카펠라 테라퓨틱스, 인크. | 암 치료용의 erbb 티로신 키나제 억제제로서의 벤즈이미다졸 유도체 |
WO2015143161A1 (en) | 2014-03-20 | 2015-09-24 | Capella Therapeutics, Inc. | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer |
US10335374B2 (en) * | 2014-12-04 | 2019-07-02 | University System of Georgia, Valdosta State University | Tablet composition for anti-tuberculosis antibiotics |
ES2805528T3 (es) | 2014-12-23 | 2021-02-12 | Sma Therapeutics Inc | Inhibidores de 3,5-diaminopirazol quinasa |
CZ2015225A3 (cs) * | 2015-03-30 | 2016-10-12 | Zentiva, K.S. | Nový krok ve způsobu potahování pelet obsahujících Tamsulosin.HCI |
JP2016193894A (ja) * | 2015-04-01 | 2016-11-17 | 京都薬品工業株式会社 | 生菌含有製剤 |
JP6618736B2 (ja) | 2015-09-01 | 2019-12-11 | 沢井製薬株式会社 | ミラベグロン含有錠剤、ミラベグロン含有製剤の製造方法及びミラベグロン含有造粒物の製造方法 |
MX2018011278A (es) | 2016-03-17 | 2019-07-08 | Thiogenesis Therapeutics Inc | Composiciones para la liberacion controlada de cisteamina y el tratamiento sistemico de trastornos sensibles a la cisteamina. |
CN108066347B (zh) * | 2016-11-16 | 2021-02-02 | 深圳万和制药有限公司 | 包含坦索罗辛和度他雄胺的口腔崩解片药物组合物 |
CN108066305B (zh) * | 2016-11-16 | 2022-09-16 | 深圳万和制药有限公司 | 改善口崩片硬度和崩解的方法和定位释放口腔崩解片 |
CN108066304B (zh) * | 2016-11-16 | 2022-09-16 | 深圳万和制药有限公司 | 具有缓释性能的坦索罗辛口腔崩解片组合物 |
CN108066297B (zh) * | 2016-11-16 | 2022-09-16 | 深圳万和制药有限公司 | 治疗老年痴呆症的定位释放美金刚口腔崩解片组合物 |
CN107616969B (zh) * | 2016-11-16 | 2020-09-18 | 杭州朱养心药业有限公司 | 迅速崩解的吡仑帕奈片剂药物组合物 |
WO2019039420A1 (ja) | 2017-08-21 | 2019-02-28 | ニプロ株式会社 | 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法 |
JP7336388B2 (ja) * | 2018-02-02 | 2023-08-31 | ニプロ株式会社 | 錠剤及びその製造方法 |
EP3768240A4 (en) * | 2018-03-19 | 2021-12-22 | Cage Bio Inc. | IONIC LIQUID COMPOSITIONS FOR THE TREATMENT OF ROSACEA |
GB202001237D0 (en) * | 2020-01-29 | 2020-03-11 | Sisteks D O O | Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772475A (en) * | 1985-03-08 | 1988-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Controlled-release multiple units pharmaceutical formulation |
JPH0780754B2 (ja) | 1986-08-06 | 1995-08-30 | エーザイ株式会社 | 多顆粒型持続性錠剤 |
JPH01135451A (ja) * | 1987-11-20 | 1989-05-29 | Mitsubishi Electric Corp | 搬送ロボット |
EP0489096B1 (en) * | 1989-08-25 | 1995-11-15 | BIOGLAN IRELAND (R & D) LIMITED | Pharmaceutical compositions and a device for administering the same |
DE69122280T2 (de) | 1990-03-01 | 1997-04-24 | Hewlett Packard Co | Minimierung von Eluatbandbreiten in der Flüssigchromatographie |
EP0447168A3 (en) * | 1990-03-16 | 1993-01-07 | Yamanouchi Pharmaceutical Co. Ltd. | Long acting granular pharmaceutical composition |
HU219349B (en) * | 1991-12-24 | 2001-03-28 | Yamanouchi Pharma Co Ltd | Intrabuccally disintegrating preparation and production thereof |
US5576014A (en) | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
PL187160B1 (pl) | 1994-01-31 | 2004-05-31 | Yamanouchi Pharma Co Ltd | Sposób wytwarzania rozpuszczalnej wewnątrzustnie formowanej tłocznie wypraski |
JPH1135451A (ja) * | 1994-07-27 | 1999-02-09 | Yamanouchi Pharmaceut Co Ltd | 口腔内溶解型錠剤およびその製造方法 |
US5824339A (en) * | 1995-09-08 | 1998-10-20 | Takeda Chemical Industries, Ltd | Effervescent composition and its production |
EP0922464B1 (en) | 1996-07-12 | 2005-03-30 | Daiichi Pharmaceutical Co., Ltd. | Quickly disintegrable compression-molded materials and process for producing the same |
JPH10182436A (ja) | 1996-10-31 | 1998-07-07 | Takeda Chem Ind Ltd | 固形医薬製剤 |
PT1001748E (pt) | 1997-07-25 | 2006-08-31 | Alpex Pharma Sa | Um processo para a preparacao de um granulado adequado para a preparacao de comprimidos rapidamente desintegraveis na boca |
US6475510B1 (en) * | 1997-12-19 | 2002-11-05 | Smithkline Beecham Corporation | Process for manufacturing bite-dispersion tablets |
HUP0101282A3 (en) | 1998-03-16 | 2005-03-29 | Yamanouchi Pharma Tech Inc | Tablets quickly disintegrating in the oral cavity and process for producing the same |
US6465009B1 (en) | 1998-03-18 | 2002-10-15 | Yamanouchi Pharmaceutical Co., Ltd. | Water soluble polymer-based rapidly dissolving tablets and production processes thereof |
JP2000128774A (ja) * | 1998-10-26 | 2000-05-09 | Tanabe Seiyaku Co Ltd | 薬物を含有する球形微粒子の製法 |
US6495177B1 (en) * | 1999-08-13 | 2002-12-17 | Warner Chilcott Laboratories Ireland Limited | Orally dissolvable nutritional supplement |
EP1269995A1 (en) | 2000-03-27 | 2003-01-02 | Kyowa Hakko Kogyo Co., Ltd. | Easy-to-take granule |
US6872405B2 (en) * | 2001-05-10 | 2005-03-29 | Yamanouchi Pharmaceutical Co., Ltd. | Quick-disintegrating tablet in buccal cavity and manufacturing method thereof |
JP4019374B2 (ja) * | 2001-07-27 | 2007-12-12 | アステラス製薬株式会社 | 口腔内速崩壊錠用徐放性微粒子含有組成物およびその製造法 |
-
2002
- 2002-07-25 JP JP2003515224A patent/JP4019374B2/ja not_active Expired - Lifetime
- 2002-07-25 US US10/206,010 patent/US7255876B2/en not_active Expired - Fee Related
- 2002-07-25 EP EP02751684A patent/EP1413294B1/en not_active Expired - Lifetime
- 2002-07-25 HU HU0302351A patent/HUP0302351A3/hu unknown
- 2002-07-25 RU RU2003102625/15A patent/RU2245136C2/ru not_active IP Right Cessation
- 2002-07-25 CA CA002419089A patent/CA2419089A1/en not_active Abandoned
- 2002-07-25 WO PCT/JP2002/007550 patent/WO2003009831A1/ja active IP Right Grant
- 2002-07-25 DE DE60237826T patent/DE60237826D1/de not_active Expired - Lifetime
- 2002-07-25 CN CN028028864A patent/CN1473035B/zh not_active Expired - Lifetime
- 2002-07-25 BR BR0205509-0A patent/BR0205509A/pt not_active IP Right Cessation
- 2002-07-25 DE DE20220604U patent/DE20220604U1/de not_active Expired - Lifetime
- 2002-07-25 AT AT02751684T patent/ATE482692T1/de not_active IP Right Cessation
- 2002-07-25 KR KR10-2003-7001324A patent/KR100530546B1/ko active IP Right Grant
- 2002-07-25 PL PL02361452A patent/PL361452A1/xx not_active IP Right Cessation
- 2002-07-25 MX MXPA03000985A patent/MXPA03000985A/es active IP Right Grant
- 2002-07-25 AU AU2002355222A patent/AU2002355222B2/en not_active Ceased
- 2002-07-25 ES ES02751684T patent/ES2351249T3/es not_active Expired - Lifetime
-
2003
- 2003-01-23 ZA ZA200300647A patent/ZA200300647B/en unknown
- 2003-08-29 CZ CZ200314578U patent/CZ14921U1/cs not_active IP Right Cessation
-
2004
- 2004-04-06 JP JP2004111671A patent/JP2004196829A/ja not_active Withdrawn
-
2005
- 2005-03-10 JP JP2005067640A patent/JP2005206608A/ja not_active Withdrawn
-
2007
- 2007-05-02 US US11/743,616 patent/US7575762B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2005206608A (ja) | 2005-08-04 |
CN1473035A (zh) | 2004-02-04 |
WO2003009831A1 (en) | 2003-02-06 |
CZ14921U1 (cs) | 2004-11-23 |
ZA200300647B (en) | 2004-07-14 |
DE20220604U1 (de) | 2004-02-26 |
KR100530546B1 (ko) | 2005-11-23 |
US20030147948A1 (en) | 2003-08-07 |
EP1413294A4 (en) | 2006-06-07 |
CN1473035B (zh) | 2012-07-18 |
DE60237826D1 (de) | 2010-11-11 |
AU2002355222B2 (en) | 2007-07-26 |
HUP0302351A2 (hu) | 2003-10-28 |
PL361452A1 (en) | 2004-10-04 |
RU2245136C2 (ru) | 2005-01-27 |
KR20030036656A (ko) | 2003-05-09 |
JPWO2003009831A1 (ja) | 2004-11-11 |
ES2351249T3 (es) | 2011-02-02 |
US20070202168A1 (en) | 2007-08-30 |
JP2004196829A (ja) | 2004-07-15 |
US7575762B2 (en) | 2009-08-18 |
CA2419089A1 (en) | 2003-03-05 |
US7255876B2 (en) | 2007-08-14 |
MXPA03000985A (es) | 2004-04-02 |
EP1413294B1 (en) | 2010-09-29 |
JP4019374B2 (ja) | 2007-12-12 |
ATE482692T1 (de) | 2010-10-15 |
HUP0302351A3 (en) | 2007-03-28 |
EP1413294A1 (en) | 2004-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0205509A (pt) | Composição compreendendo partìculas finas de liberação prolongada para comprimidos de rápida desintegração na cavidade bucal e método de fabricação da mesma | |
Mozayeni et al. | Cytotoxicity of calcium enriched mixture cement compared with mineral trioxide aggregate and intermediate restorative material | |
NZ600640A (en) | Abuse-resistant formulations | |
WO2008052033A3 (en) | Ibuprofen composition | |
BRPI0707044B8 (pt) | comprimido matricial insolúvel em água e processo de fabricação de comprimidos matriciais | |
BR0209489A (pt) | Composições farmacêuticas | |
BRPI0608853B8 (pt) | composições farmacêuticas e processo para a fabricação de microgrânulos de rifaximina gastrorresistentes | |
WO2003086321A3 (en) | Modified release minerals | |
PE20061449A1 (es) | Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion | |
BRPI0820308A8 (pt) | composições farmacêuticas | |
BR9811987A (pt) | Comprimidos de metil celulose de rápida desintegração | |
MX2009008952A (es) | Microesferas que comprenden una matriz de sustancia activa resistente a jugo gastrico. | |
NZ601200A (en) | Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) | |
MX2008012731A (es) | Tabletas de paracetamol de liberacion rapida. | |
ATE418327T1 (de) | Pharmazeutische granulatzusammensetzungen mit sofortiger freisetzung und kontinuierliches verfahren zu ihrer herstellung | |
TW200621267A (en) | Oral disintegrative N-acetylglucosamine tablet and manufacture thereof | |
WO2007134158A3 (en) | Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy | |
TW200501965A (en) | Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle | |
ATE424814T1 (de) | Schnell zerfallende im mund dispergierbare zusammensetzung mit nicht-filamentösen mitverarbeiteten polyol-teilchen und verkieselter mikrokristalliner cellulose | |
BR9911648A (pt) | Composição farmacêutica de liberação controlada e processo de liberação de agente farmaceuticamente ativo | |
ATE486583T1 (de) | Pharmazeutische zusammensetzung enthaltend anastrozol | |
WO2007051542A3 (de) | Kompositmaterialien aus calciumverbindungen und spezieller gelatine | |
WO2003063824A3 (en) | Pharmaceutical composition | |
HRP20080452T3 (en) | Orally disintegrating pharmaceutical composition comprising risperidone | |
AR111434A2 (es) | Material granular, cápsula resistente al agua, comprimido compactado de material granular, proceso para preparar el material granular y usos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: ASTELLAS PHARMA INC. (JP) Free format text: ALTERADO DE: YAMANOUCHI PHARMACEUTICAL CO., LTD. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2156 DE 02/05/2012. |